Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Gild crawled time : 14:03 save search
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-24 (Crawled : 14:03) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 0.52%
C: 0.13%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 8.21%
H: 1.89%
C: -0.83%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: 0.6%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.37%
H: 1.55%
C: 0.28%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 0.0%
H: 10.77%
C: 10.77%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.29%
H: 0.8%
C: 0.17%
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 0.32%
H: 0.87%
C: 0.26%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.18%
H: 2.2%
C: 0.61%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.06%
H: 0.35%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.71%
H: 1.09%
C: 0.22%
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Published: 2021-02-10 (Crawled : 14:03) - globenewswire.com
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.06%
H: 1.58%
C: 0.04%
GLPG | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -13.39%
H: 2.15%
C: -5.04%
phase 3 trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.